|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 16-07-20 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 16-07-15 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 2014-12-08 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2016-08-24 | |
| Director/Board Member | 58 | 2016-08-24 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.19% | +11.31% | +67.86% | +150.58% | 1,224B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 662B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 249B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 205B | |
| Average | +1.73% | +2.59% | +46.59% | +83.14% | 464.09B | |
| Weighted average by Cap. | +1.17% | +3.04% | +50.91% | +98.22% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
